APR July/August 2023 - 9

AMERICAN PHARMACEUTICAL REVIEW
Social Media Connections
U.S. FDA
@US_FDA
@FDACBER is hosting their next virtual town hall
Aug. 30 to answer questions related to nonclinical
assessment of cell therapy and gene therapy products.
Registrants can submit questions in advance of the
event. Register now: https://bit.ly/3O0ds65
PhRMA
@PhRMA
Just released: The latest Patient Experience Survey
reveals the difficulties patients experience with accessing
and affording health care, including practices that
put up barriers between patients and their medicines
and jeopardize access to innovation: https://onphr.
ma/3Q7gFTa
U.S. Pharmacopeia
@USPharmacopeia
USP has officially launched the Continuous
Manufacturing Knowledge Center (CMKC), an online
tool accessible anywhere at any time, allowing
unlimited opportunities to research & collaborate.
Sign up for free now to become a #CMKC Community
member. https://cmkc.usp.org
World Health Organization (WHO)
@WHO
Health and care workers play an important role in helping
people understand and use #SelfCare approaches and
tools - whether to self-test for pregnancy, COVID-19 or
HIV, manage their fertility or self-monitor chronic health
conditions https://bit.ly/3OqQMfv
EU Medicines Agency
@EMA_News
Health Canada and PHAC
@GovCanHealth
New public consultation open! Comment now on a
draft reflection paper on artificial intelligence & machine
learning in the development, use and regulation
of medicines for people and animals.
We know that #NaturalHealthProducts (NHPs) are
important to Canadians. This is why we are working
to introduce improvements to ensure the continued
availability of safe and high quality NHPs. Find out more:
https://ow.ly/xmXi50Piooi
CDC
@CDCgov
RSV can cause severe disease in adults 60 and older
who have certain chronic medical conditions, such as
heart or lung disease, or weakened immune systems.
Talk to your healthcare professional to see if an #RSV
vaccine is right you.
Pfizer Inc.
@pfizer_news
Data published in @NEJM on our Group B streptococcus
(GBS) maternal vaccine candidate suggest that maternal
vaccination may help protect infants against invasive GBS.
Read more: https://pfizer.com/news/press-release/pressrelease-detail/pfizer-announces-new-england-journalmedicine-publication
Connect
with American Pharmaceutical Review at:
facebook.com/AmericanPharmaceuticalReview
twitter.com/ampharmrev
linkedin.com/groups/American-Pharmaceutical-Review-3889659
www.americanpharmaceuticalreview.com |
| 9
https://bit.ly/3O0ds65 https://onphr https://cmkc.usp.org https://bit.ly/3OqQMfv https://www.ow.ly/xmXi50Piooi https://www.pfizer.com/news/press-release/press http://www.facebook.com/AmericanPharmaceuticalReview http://www.twitter.com/ampharmrev http://www.linkedin.com/groups/American-Pharmaceutical-Review-3889659 http://www.americanpharmaceuticalreview.com

APR July/August 2023

Table of Contents for the Digital Edition of APR July/August 2023

APR July/August 2023 - Cover1
APR July/August 2023 - Cover2
APR July/August 2023 - 1
APR July/August 2023 - 2
APR July/August 2023 - 3
APR July/August 2023 - 4
APR July/August 2023 - 5
APR July/August 2023 - 6
APR July/August 2023 - 7
APR July/August 2023 - 8
APR July/August 2023 - 9
APR July/August 2023 - 10
APR July/August 2023 - 11
APR July/August 2023 - 12
APR July/August 2023 - 13
APR July/August 2023 - 14
APR July/August 2023 - 15
APR July/August 2023 - 16
APR July/August 2023 - 17
APR July/August 2023 - 18
APR July/August 2023 - 19
APR July/August 2023 - 20
APR July/August 2023 - 21
APR July/August 2023 - 22
APR July/August 2023 - 23
APR July/August 2023 - 24
APR July/August 2023 - 25
APR July/August 2023 - 26
APR July/August 2023 - 27
APR July/August 2023 - 28
APR July/August 2023 - 29
APR July/August 2023 - 30
APR July/August 2023 - 31
APR July/August 2023 - 32
APR July/August 2023 - 33
APR July/August 2023 - 34
APR July/August 2023 - 35
APR July/August 2023 - 36
APR July/August 2023 - 37
APR July/August 2023 - 38
APR July/August 2023 - 39
APR July/August 2023 - 40
APR July/August 2023 - 41
APR July/August 2023 - 42
APR July/August 2023 - 43
APR July/August 2023 - 44
APR July/August 2023 - 45
APR July/August 2023 - 46
APR July/August 2023 - 47
APR July/August 2023 - 48
APR July/August 2023 - 49
APR July/August 2023 - 50
APR July/August 2023 - 51
APR July/August 2023 - 52
APR July/August 2023 - 53
APR July/August 2023 - 54
APR July/August 2023 - 55
APR July/August 2023 - 56
APR July/August 2023 - 57
APR July/August 2023 - 58
APR July/August 2023 - 59
APR July/August 2023 - 60
APR July/August 2023 - 61
APR July/August 2023 - 62
APR July/August 2023 - 63
APR July/August 2023 - 64
APR July/August 2023 - 65
APR July/August 2023 - 66
APR July/August 2023 - 67
APR July/August 2023 - 68
APR July/August 2023 - 69
APR July/August 2023 - 70
APR July/August 2023 - 71
APR July/August 2023 - 72
APR July/August 2023 - 73
APR July/August 2023 - 74
APR July/August 2023 - 75
APR July/August 2023 - 76
APR July/August 2023 - 77
APR July/August 2023 - 78
APR July/August 2023 - 79
APR July/August 2023 - 80
APR July/August 2023 - 81
APR July/August 2023 - 82
APR July/August 2023 - 83
APR July/August 2023 - 84
APR July/August 2023 - 85
APR July/August 2023 - 86
APR July/August 2023 - 87
APR July/August 2023 - 88
APR July/August 2023 - 89
APR July/August 2023 - 90
APR July/August 2023 - 91
APR July/August 2023 - 92
APR July/August 2023 - 93
APR July/August 2023 - 94
APR July/August 2023 - 95
APR July/August 2023 - 96
APR July/August 2023 - Cover3
APR July/August 2023 - Cover4
https://www.nxtbookmedia.com